Services

Life Sciences Arbitration

Overview

CRA’s life sciences arbitration support is grounded in a comprehensive, insiders’ understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 25 years, we have consulted directly with major life science companies, law firms, and regulatory agencies around the globe. This deep industry knowledge is complemented by our extensive experience in complex litigation. CRA’s involvement has helped our clients solve their most challenging strategic problems and resolve their most contentious disputes.

01

AAA dispute in commercially reasonable efforts to market a hospital administered drug

CRA expert, Dr. Sean Sheridan considered the Respondent’s efforts as they relate to the obligations of the licensing agreement and evaluated those efforts...
View engagement
02

Alleged breach of license agreement

CRA was retained by the claimant in an arbitration regarding the breach of a license agreement relating to pharmaceutical manufacturing technology. Dr. Sean...
View engagement
03

Valuation of contributions to codeveloped intellectual property

CRA was retained to serve as a neutral advisor to the Tribunal in an international arbitration involving a licensing dispute between two agricultural sciences...
View engagement